OpenNashPodcasts

Person

Timo Minssen

1 episodes · 7 quoted claims

Timo Minssen cites the World Health Organization as estimating about 2 million different kinds of medical devices on the world market.

“the WHO estimates that today there are approximately 2 million different kinds of medical devices on the world market.”

Microsoft Research Podcast · 0:17:02

Timo Minssen says the FDA had authorized more than 1,000 AI and machine-learning-enabled medical devices as of its latest update he knew of.

“the FDA has authorized more than 1 ,000 AI machine learning enabled medical devices.”

Microsoft Research Podcast · 0:17:02

Timo Minssen says medical devices range from simple items like tongue depressors and thermometers to complex ones like insulin pumps, MRI machines and implantable pacemakers.

“from very simple devices, such as tongue depressors, contact lenses and thermometers, to more complex devices such as block pressure monitors, insulin pumps, MRI machines, implantable pacemakers”

Microsoft Research Podcast · 0:17:45

Timo Minssen says pre-market device evaluations include bench testing, biocompatibility assessments and software validation as part of a manufacturer's submission.

“Premarket evaluations include functional bench testing, biocompatibility for example, assessments and software validation, all of which are integral components of a manufacturer's submission.”

Microsoft Research Podcast · 0:22:19

Timo Minssen says evidence that an AI-enabled device is becoming more precise and safer could sometimes lower its risk category.

“you could also sometimes lower the risk category by finding evidence that these devices are actually becoming more precise and safer.”

Microsoft Research Podcast · 0:23:45

Timo Minssen says regulatory sandboxes originated in the financial sector and are now spreading to areas such as synthetic biology, gene editing, AI and quantum technology.

“this idea of regulatory sandboxes has been developing originally in the financial sector. And it is now penetrating into other sectors, including synthetic biology, emerging biotechnologies, gene editing, AI, quantum technology as well.”

Microsoft Research Podcast · 0:27:29

Timo Minssen says regulatory sandboxes raise competition law questions about who may enter and how participants compete after leaving.

“There are issues relating to competition law, for example, which you call antitrust law in the US, because the question is who can enter the sandbox and how may they compete after they exit the sandbox.”

Microsoft Research Podcast · 0:28:20